• Molecular NameFenoterol
  • SynonymFenoterolum [inn-latin]; Phenoterol
  • Weight303.358
  • Drugbank_IDDB01288
  • ACS_NO13392-18-2
  • Show 3D model
  • LogP (experiment)0.83
  • LogP (predicted, AB/LogP v2.0)1.42
  • pka8.5, 10.0
  • LogD (pH=7, predicted)0.52
  • Solubility (experiment)100 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-1.42
  • LogSw (predicted, AB/LogsW2.0)35.32
  • Sw (mg/ml) (predicted, ACD/Labs)2.71
  • No.of HBond Donors5
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds6
  • TPSA92.95
  • StatusFDA approved
  • AdministrationInhaled
  • PharmacologyAn asthma medication designed to open up the airways to the lungs. It is classed as a beta agonist.
  • Absorption_value60.0
  • Absorption (description)Rapidly but incompletely absorbed after inhalation or oral administration.
  • Caco_2N/A
  • Bioavailability2.0
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmIt undergoes extensive first-pass metabolism by sulfate conjugation.
  • Half life6~7 h
  • ExcretionAbout 35% of an oral dose is excreted in the urine in 24 h, mainly as the inactive sulfate conjugate, and less than 2% as unchanged drug; about 40% of an oral dose is eliminated in the faeces.
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A